Long-term clinical outcomes from real-world experience of left atrial appendage exclusion with LARIAT device.
Valay ParikhKrzysztof BartusRadoslaw LitwinowiczMohit K TuragamJerzy SadowskiBoguslaw KapelakMagdalena BartusJakub PodolecMaciej BrzezinskiDan MusatAbdi RasekhSuneet MittalJie ChengNitish BadhwarRandall LeeDhanunjaya R LakkireddyPublished in: Journal of cardiovascular electrophysiology (2019)
Long-term data from routine clinical practice from our study suggests that LAA exclusion with LARIAT device is an effective treatment in management of nonvalvular AF patients with high risk of stroke, bleeding, and mortality. Further randomized trials, such as aMAZE, will provide more insight in this expanding field.
Keyphrases
- left atrial appendage
- atrial fibrillation
- clinical practice
- catheter ablation
- oral anticoagulants
- direct oral anticoagulants
- cardiovascular events
- electronic health record
- risk factors
- cardiovascular disease
- type diabetes
- coronary artery disease
- venous thromboembolism
- combination therapy
- machine learning
- artificial intelligence